SARS-CoV-2 — A Biological Warfare Weapon?
Story at-a-glance
- Francis Boyle, who drafted the Biological Weapons Anti-Terrorism Act of 1989, believes COVID-19 is a weaponized pathogen that escaped from Wuhan City’s Biosafety Level (BSL) 4 facility
- A Lancet paper published by physicians who treated some of the first COVID-19 patients in China showed that patient zero, the one believed to have started the transmission, was nowhere near the Wuhan seafood market. What’s more, there were no bats sold in or even close to the market
- SARS-CoV-2 appears to be a benign bat coronavirus modified to integrate spike proteins that allows the virus to enter human cells by attaching to ACE-2 receptors
- The virus also appears to have been modified to integrate an envelope protein from HIV called GP141, which tends to impair the immune system. A third modification appears to involve nanotechnology, which allows the virus to remain airborne longer
Francis Boyle, a former advisory board member for the Council for Responsible Genetics, is a professor of international law at the University of Illinois College of Law.
His educational background includes an undergraduate degree from the University of Chicago, a juris doctor (lawyer) degree from Harvard and a Ph.D. in political science. For decades, he’s advocated against the development and use of bioweapons, which he suspects COVID-19 is.
Comments